Product Specs FIBRYGA
Manufacturer Name Octapharma
Indications FIBRYGA is indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia
Contraindications Anaphylactic or severe reactions to FIBRYGA or its components.
Viral Safety Process Solvent/detergent and nanofiltration
Product Half-Life 75.9 ± 23.8 hours
Manufacturing Method Human-Derived Plasma
Storage Requirements
  • Store at 2°C to 25°C (36°F to 77°F)
  • Do not freeze.
  • Shelf Life 30 months from manufactured date
    Nominal Vial Size & Diluent Volume 1 g/50 mL

    Return to Manufacturer Name listing Return to Factor Type listing